




Searching News Database: Carbidopa
HSMN NewsFeed - 20 Jun 2018
Amneal Announces Patent Litigation Settlement Agreement with Actavis Concerning Rytary(R)
Amneal Announces Patent Litigation Settlement Agreement with Actavis Concerning Rytary(R)
HSMN NewsFeed - 31 Jan 2018
Intec Pharma Names R. Michael Gendreau, M.D., Ph.D. as Chief Medical Officer
Intec Pharma Names R. Michael Gendreau, M.D., Ph.D. as Chief Medical Officer
HSMN NewsFeed - 11 Apr 2017
Valeo Pharma and Zambon form partnership for Parkinson's Disease Treatment Xadago(R) (safinamide) in Canada
Valeo Pharma and Zambon form partnership for Parkinson's Disease Treatment Xadago(R) (safinamide) in Canada
HSMN NewsFeed - 21 Dec 2011
Impax Pharmaceuticals Submits New Drug Application for IPX066 in Parkinson’s Disease
Impax Pharmaceuticals Submits New Drug Application for IPX066 in Parkinson’s Disease
HSMN NewsFeed - 15 Apr 2010
Impax Pharmaceuticals Completes Enrollment in APEX-PD Phase III Trial of IPX066 in Parkinson's Disease
Impax Pharmaceuticals Completes Enrollment in APEX-PD Phase III Trial of IPX066 in Parkinson's Disease
HSMN NewsFeed - 30 Sep 2009
Mylan Receives FDA Approval for Generic Version of Parkinson's Treatment Sinemet(R)
Mylan Receives FDA Approval for Generic Version of Parkinson's Treatment Sinemet(R)
HSMN NewsFeed - 9 Jan 2009
Azur Pharma Announces the Licensing of Niravam, Parcopa, Kemstro and Fluxid From UCB
Azur Pharma Announces the Licensing of Niravam, Parcopa, Kemstro and Fluxid From UCB
HSMN NewsFeed - 22 Sep 2008
Mylan Receives FDA Approval for Generic Version of Parkinson's Treatment Parcopa(R) ODT
Mylan Receives FDA Approval for Generic Version of Parkinson's Treatment Parcopa(R) ODT
HSMN NewsFeed - 4 Aug 2008
Meda Acquires European Businesses from American Valeant and Enters the Russian Market
Meda Acquires European Businesses from American Valeant and Enters the Russian Market
HSMN NewsFeed - 28 Feb 2008
Kyowa Hakko Receives Not Approvable Letter from FDA for Istradefylline (KW-6002)
Kyowa Hakko Receives Not Approvable Letter from FDA for Istradefylline (KW-6002)
HSMN NewsFeed - 30 Jan 2008
IMPAX Receives FDA Non-Approvable Letter for Vadova(R); Company Considering Options
IMPAX Receives FDA Non-Approvable Letter for Vadova(R); Company Considering Options
HSMN NewsFeed - 18 Jul 2006
Valeant Pharmaceuticals Announces Availability of Zelapar(R) for Parkinson's Disease Patients
Valeant Pharmaceuticals Announces Availability of Zelapar(R) for Parkinson's Disease Patients
Additional items found! 12

Members Archive contains
12 additional stories matching:
Carbidopa
(Password required)
Carbidopa
(Password required)